Endoscopic Laser Ablation of Nondysplastic Barrett's Epithelium: Is It Worthwhile?

被引：34

作者：

Bonavina L. ^{[1
,3
]}

Ceriani C. ^{[1
]}

Carazzone A. ^{[1
]}

Segalin A. ^{[1
]}

Ferrero S. ^{[2
]}

Peracchia A. ^{[1
]}

机构：

[1] Dept. of Gen. and Oncologic Surgery, University of Milan, Ist. Ricovero Cura a Carattere Sci., Milano

[2] Department of Pathology, University of Milan, Ist. Ricovero Cura a Carattere Sci., Milano

[3] Ist. di Chir. Gen. e Oncol. Chir., Ospedale Maggiore Policlinico, IRCCS, 20122 Milano

来源：

Journal of Gastrointestinal Surgery | 1999年 / 3卷 / 2期

关键词：

Adenocarcinoma; Barrett's esophagus; Nd:YAG laser; Nissen fundoplication; Proton pump inhibitors;

D O I：

10.1016/S1091-255X(99)80033-X

中图分类号：

学科分类号：

摘要：

The clinical value of endoscopic ablation of nondysplastic Barrett's epithelium is controversial. It has been stated that ablation, combined with acid suppression or antireflux surgery, may reduce the risk of adenocarcinoma, thereby obviating the need for endoscopic surveillance in these patients. Eighteen symptomatic patients were enrolled in a prospective study of Nd:YAG laser ablation of Barrett's esophagus followed by treatment with proton pump inhibitors or antireflux surgery. All patients had intestinal metaplasia and no associated dysplasia or carcinoma. Laser treatment was performed with noncontact fibers and a power output of 60 watts. The mean number of treament sessions was three (range 1 to 5), and the mean energy delivered during each session was 2800 joules (range 600 to 4800 joules). All patients were given a standard dose of omeprazole (40 mg/day) throughout the study period. In two patients a mild distal esophageal stricture occurred and required a single dilatation. Macroscopic and histologic eradication of the specialized columnar epithelium was documented in 8 of 12 patients with tongues of Barrett's metaplasia, in one of four patients with circumferential Barrett's metaplasia, and in two of two patients with short-segment Barrett's esophagus. In five patients (28%) only a partial ablation could be achieved despite repeated laser treatment. Two patients (11%), one with tongues and the other with circumferential Barrett's metaplasia, were considered nonresponders. Adenocarcinoma undermining regenerated squamous epithelium was found, 6 months after eradication, in one patient who underwent esophagogastric resection. Twelve patients agreed to undergo antireflux surgery. Over a mean follow-up period of 14 months (range 4 to 32 months), two patients presented with recurrent Barrett's metaplasia: one at 8 months after successful Nissen fundoplication and the other after 1 year of continuous omeprazole treatment. Progression of Barrett's metaplasia was found in two other patients receiving pharmacologic therapy in whom a partial response to laser treatment had been obtained. In conclusion, Nd:YAG laser therapy of nondysplastic Barrett's esophagus, performed in conjunction with omeprazole treatment and followed by antireflux surgery, allows a partial regression of specialized columnar epithelium in most patients. However, this is a time-consuming procedure that produced only temporary eradication, did not prove effective in reducing cancer risk, and did not obviate the need for endoscopic surveillance.

引用

页码：194 / 199

页数：5

共 22 条

[1]

Crooks G., Lichtenstein G., Clinical implications of Barrett's esophagus, Arch Intern Med, 156, pp. 2174-2180, (1996)

[2]

Streitz J., Andrews C., Ellis H., Endoscopic surveillance of Barrett's esophagus. Does it help?, J Thorac Cardiovasc Surg, 105, pp. 383-388, (1993)

[3]

Peters J., Clark G., Ireland A., Chandrasoma P., Smyrk T., DeMeester T., Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients, J Thorac Cardiovasc Surg, 108, pp. 813-822, (1994)

[4]

Sharma P., Sampliner R., Camargo E., Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus, Am J Gastroenterol, 92, pp. 582-585, (1997)

[5]

Skinner D., Walther B., Riddell R., Schmidt H., Iascone C., DeMeester T., Barrett's esophagus. Comparison of benign and malignant cases, Ann Surg, 198, pp. 554-566, (1983)

[6]

Williamson W., Ellis H., Gibb S., Et al., Effect of antireflux operation on Barrett's mucosa, Ann Thorac Surg, 49, pp. 537-542, (1990)

[7]

Attwood S., Barlow A., Norris T., Watson A., Barrett's oesophagus: Effect of antireflux surgery on symptom control and development of complications, Br J Surg, 79, pp. 1050-1053, (1992)

[8]

Ortiz A., Martinez De Haro L., Parrilla P., Morales G., Molina J., Bermejo J., Liron H., Aguilar J., Conservative treatment versus antireflux surgery in Barrett's oesophagus: Long-term, results of a prospective study, Br J Surg, 83, pp. 274-278, (1996)

[9]

Laukka M., Wang K., Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus, Gastrointest Endosc, 42, pp. 59-63, (1995)

[10]

Overholt B., Panjehpour M., Barrett's esophagus: Photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer, Gastrointest Endosc, 42, pp. 64-69, (1995)

← 1 2 3 →